Bexarotene‐induced leukopenia may be different from bone marrow suppression caused by cytotoxic agents, because of the neutrophil proliferation and differentiation regulated by RXR‐α expression.21 Dose reduction of bexarotene would help bring about early improvement in the neutrophil count. Here, RXRA is linked to Decreased total leukocyte count.